Kronos Bio, Inc. - Common Stock (KRON)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Total 13F shares
35,955,919
Share change
-1,189,301
Total reported value
$753,633,856
Price per share
$20.96
Number of holders
80
Value change
-$25,676,168
Number of buys
36
Number of sells
25

Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q3 2021

As of 30 Sep 2021 Kronos Bio, Inc. - Common Stock (KRON) had 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 35,955,919 shares of stock of the company.
Largest 10 holders included Omega Fund Management, LLC, VANGUARD GROUP INC, Capital World Investors, BlackRock Inc., PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, JPMORGAN CHASE & CO, Wildcat Capital Management, LLC, and Alphabet Inc..
This table shows 80 institutional shareholders of the security as of 30 Sep 2021.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.